Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-24-027636
Filing Date
2024-11-25
Accepted
2024-11-25 16:33:40
Documents
1
Period of Report
2024-11-13

Document Format Files

Seq Description Document Type Size
1 form3-11252024_091136.html 3  
1 form3-11252024_091136.xml 3 10136
  Complete submission text file 0001415889-24-027636.txt   13525
Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116 6177782500
RA Capital Healthcare Fund LP (Reporting) CIK: 0001315082 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39782 | Film No.: 241496423

Mailing Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116
Business Address 200 BERKELEY STREET, 18TH FLOOR BOSTON MA 02116 617-778-2500
RA CAPITAL MANAGEMENT, L.P. (Reporting) CIK: 0001346824 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39782 | Film No.: 241496424

Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address
Kolchinsky Peter (Reporting) CIK: 0001384859 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39782 | Film No.: 241496422

Mailing Address 200 BERKELEY STREET 18TH FLOOR BOSTON MA 02116
Business Address
Shah Rajeev M. (Reporting) CIK: 0001619841 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39782 | Film No.: 241496421

Mailing Address 5858 HORTON STREET #455 EMERYVILLE CA 94608
Business Address 5858 HORTON STREET #455 EMERYVILLE CA 94608 5105052680
4D Molecular Therapeutics, Inc. (Issuer) CIK: 0001650648 (see all company filings)

IRS No.: 473506994 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)